{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12(1)"],"submitter":["Caldi Gomes L"],"funding":["Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain, Göttingen, Germany (PL).","Bridging Funds from the Göttingen Graduate Center for Neurosciences, Biophysics and Molecular Biosciences (LCG);"],"pubmed_abstract":["<h4>Background</h4>Parkinson's disease (PD) is the second most common neurodegenerative disorder whose prevalence is rapidly increasing worldwide. The molecular mechanisms underpinning the pathophysiology of sporadic PD remain incompletely understood. Therefore, causative therapies are still elusive. To obtain a more integrative view of disease-mediated alterations, we investigated the molecular landscape of PD in human post-mortem midbrains, a region that is highly affected during the disease process.<h4>Methods</h4>Tissue from 19 PD patients and 12 controls were obtained from the Parkinson's UK Brain Bank and subjected to multi-omic analyses: small and total RNA sequencing was performed on an Illumina's HiSeq4000, while proteomics experiments were performed in a hybrid triple quadrupole-"],"journal":["Clinical and translational medicine"],"pagination":["e692"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8797064"],"repository":["biostudies-literature"],"pubmed_title":["Multi-omic landscaping of human midbrains identifies disease-relevant molecular targets and pathways in advanced-stage Parkinson's disease."],"pmcid":["PMC8797064"],"pubmed_authors":["Maass F","Lohmann K","Caldi Gomes L","Galhoz A","Jain G","Carboni E","Bahr M","Klein C","Menden MP","Fischer A","Roser AE","Lingor P","Barski E","Lenz C"],"additional_accession":[]},"is_claimable":false,"name":"Multi-omic landscaping of human midbrains identifies disease-relevant molecular targets and pathways in advanced-stage Parkinson's disease.","description":"<h4>Background</h4>Parkinson's disease (PD) is the second most common neurodegenerative disorder whose prevalence is rapidly increasing worldwide. The molecular mechanisms underpinning the pathophysiology of sporadic PD remain incompletely understood. Therefore, causative therapies are still elusive. To obtain a more integrative view of disease-mediated alterations, we investigated the molecular landscape of PD in human post-mortem midbrains, a region that is highly affected during the disease process.<h4>Methods</h4>Tissue from 19 PD patients and 12 controls were obtained from the Parkinson's UK Brain Bank and subjected to multi-omic analyses: small and total RNA sequencing was performed on an Illumina's HiSeq4000, while proteomics experiments were performed in a hybrid triple quadrupole-","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jan","modification":"2025-05-18T13:24:05.331Z","creation":"2025-02-19T01:45:58.145Z"},"accession":"S-EPMC8797064","cross_references":{"pubmed":["35090094"],"doi":["10.1002/ctm2.692"]}}